Skip to main content
Livermore
Livermore
ZHEN

Eloxx Pharmaceuticals, Inc.

ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001035354

No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.

Holders of 5% or more of ELOX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eloxx Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ELOX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Domicilium Real Estate Fund III LP13G19.99%855.0K shares+15.09 ppfrom 4.90%Jun 5, 20262 filingsJun 17, 2026SEC
Domicilium Real Estate Fund III LP13G18.60%1.41M sharesNewMay 4, 20261 filingMay 4, 2026SEC
Coastlands Capital LP13G9.99%410.5K shares+5.00 ppfrom 4.99%May 1, 20263 filingsJun 17, 2026SEC
Invus Global Management, LLC13G9.99%403.6K sharesNewJun 15, 20261 filingJun 15, 2026SEC
EcoR1 Capital, LLC13G9.90%403.6K sharesNewJun 16, 20261 filingJun 16, 2026SEC
Stonepine Capital Management, LLC13G9.90%403.2K sharesNewJun 16, 20261 filingJun 16, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

9 Schedule 13D and 13G filings on Eloxx Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ELOX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20264:53 PM ETSamsara BioCapital, L.P.and 4 others13G9.90%403.6K sharesNewJun 10, 2026SEC
Aug 14, 20264:36 PM ETNantahala Capital Management, LLCand 2 others13G9.91%400.0K sharesNewJun 30, 2026SEC
Jul 27, 20267:56 AM ETStandard Life Aberdeen plcand 1 other13G9.91%400.0K sharesNewJun 30, 2026SEC
Jun 17, 20267:15 PM ETCoastlands Capital LPand 4 others13G9.99%410.5K shares+5.00 ppfrom 4.99%Jun 10, 2026SEC
Jun 17, 20265:18 PM ETDomicilium Real Estate Fund III LPand 6 others13G19.99%855.0K shares+15.09 ppfrom 4.90%Jun 5, 2026SEC
Jun 16, 20267:10 PM ETEcoR1 Capital, LLCand 2 others13G9.90%403.6K sharesNewJun 9, 2026SEC
Jun 16, 20266:04 PM ETStonepine Capital Management, LLCand 3 others13G9.90%403.2K sharesNewJun 9, 2026SEC
Jun 15, 20266:02 PM ETInvus Global Management, LLCand 7 others13G9.99%403.6K sharesNewJun 9, 2026SEC
Jun 5, 202610:47 AM ETDomicilium Real Estate Fund III LPand 3 others13G/A4.90%23.5K shares–Below 5%May 27, 2026SEC
May 29, 20269:55 PM ETCoastlands Capital LPand 4 others13G/A4.99%266.5K shares−11.52 ppfrom 16.51%Below 5%May 27, 2026SEC
May 4, 20266:18 PM ETDomicilium Real Estate Fund III LPand 3 others13G18.60%1.41M sharesNewApr 27, 2026SEC
May 1, 20269:55 PM ETCoastlands Capital LPand 4 others13G16.51%1.25M sharesNewApr 27, 2026SEC
Feb 13, 2023Roche Finance Ltd13G/AOld format–––SEC
Feb 14, 2022Roche Finance Ltd13G/AOld format–––SEC
Feb 3, 2022LSP V Cooperatieve U.A.13D/AOld format–––SEC
Jun 29, 2021Gurnet Point L.P.13GOld format–New–SEC
Jun 14, 2021Roche Finance Ltd13GOld format–New–SEC
May 21, 2021Pontifax Management III G.P. (2011) Ltd.13D/AOld format–––SEC
Apr 13, 2021Advent Life Sciences LLP13DOld format–New–SEC
Feb 11, 2021Menora Mivtachim Holdings Ltd.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Eloxx Pharmaceuticals, Inc. shares.

No Form 144 notices for Eloxx Pharmaceuticals, Inc. are on file.